Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
84.84
+2.50 (3.04%)
Feb 17, 2026, 4:00 PM EST - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $6.79 billion as of February 18, 2026. Its market cap has increased by 164.70% in one year.
Market Cap
6.79B
Enterprise Value
5.89B
1-Year Change
164.70%
Ranking
Category
Stock Price
$84.84
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $6.79B, an increase of 713.33%. That is a compound annual growth rate of 46.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 6.79B | 9.03% |
| Dec 31, 2025 | 6.22B | 138.91% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytokinetics | 8.10B |
| Krystal Biotech | 8.02B |
| Nuvalent | 7.83B |
| Vaxcyte | 7.77B |
| Belite Bio | 6.57B |
| Rhythm Pharmaceuticals | 6.54B |
| Mirum Pharmaceuticals | 6.17B |
| ImmunityBio | 5.86B |